Monday, August 15, 2022
Home Low Dose Naltrexone, LDN, and Chronic Lyme Disease Low Dose Naltrexone, LDN, and Chronic Lyme Disease

Low Dose Naltrexone, LDN, and Chronic Lyme Disease

Low-Dose Naltrexone, LDN, Naltrexone, LDN Research Trust, Chronic Lyme Disease, fibromyalgia, HIV, AIDS, cancer, bacterial, Borrelial burgdorferi, infections, FDA, alcohol, opioid, medicines, pain, cough, diarrhea, ReVia, Vivitrol, detoxification, University of Alabama, Erythema migrans, Johns Hopkins University School of Medicine, Johns Hopkins

Low Dose Naltrexone (4.5 mg before bed) reduces cytokine levels and improves immune function in the body; it is helpful in relieving the chronic symptoms of pain, inflammation and auto-immune response in chronic Lyme Disease infections; these benefits can extend to fibromyalgia, HIV/AIDS and even cancer.